LBA78 Updated efficacy and safety of vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT): One-year follow-up from the MOTION phase III trial
H. Gelderblom, Vivek A. Bhadri, S. Stacchiotti, Sebastian Bauer, Andrew J. Wagner, Meike van de Sande, Nicholas M. Bernthal, Albiruni Ryan Abdul Razak, A. Italiano, M. Ahmed, Axel Le Cesne, Christopher Tait, A. Saunders, B. Harrow, Manu Sharma, R. Ruiz-Soto, M.L. Sherman, Jean Yves Blay, W.D. Tap (2024). LBA78 Updated efficacy and safety of vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT): One-year follow-up from the MOTION phase III trial. , 35, DOI: https://doi.org/10.1016/j.annonc.2024.08.2321.
